Tag: Vivasure Medical
Vivasure Medical submits premarket approval to FDA for PerQseal Elite closure...
Vivasure Medical has announced the submission of a premarket approval application to the US Food and Drug Administration (FDA) for its PerQseal Elite vascular...
Vivasure Medical announces first enrolment in pivotal PATCH study
Vivasure Medical has announced it has enrolled the first patients in the company’s PerQseal PATCH clinical study, a multicentre, single-arm, pivotal study evaluating the...
Vivasure Medical announces Series D financing to advance portfolio of PerQseal...
Vivasure Medical has announced the closing of the first tranche of €22 million (US$23 million) as part of its Series D financing round that...
First patient enrolled in Frontier IV clinical trial of PerQseal large...
Vivasure Medical has announced the successful enrolment of the first patient in the Frontier IV clinical study, a non-randomised multicentre international trial, designed to...
